Publications
2011
Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection.
Gratz N,
Hartweger H,
Matt U,
Kratochvill F,
Janos M,
Sigel S,
Drobits B,
Li XD,
Knapp S,
Kovarik P.
PLoS Pathog. 2011 May;7(5):e1001345.
2012
Apolipoprotein B100 is a suppressor of Staphylococcus aureus-induced innate immune response in humans and mice.
Sigel S,
Bunk S,
Meergans T,
Doninger B,
Stich K,
Stulnig T,
Derfler K,
Hoffmann J,
Deininger S,
von Aulock S,
Knapp S.
Eur J Immunol. 2012 Jul 18. doi: 10.1002/eji.201242564. [Epub ahead of print].
2013
Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer.
Zielinski C,
Knapp S,
Mascaux C,
Hirsch F.
Ann Oncol. 2013 May; 24(5): 1170–1179.
2013
Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes.
Warszawska JM,
Gawish R,
Sharif O,
Sigel S,
Doninger B,
Lakovits K,
Mesteri I,
Nairz M,
Boon L,
Spiel A,
Fuhrmann V,
Strobl B,
Müller M,
Schenk P,
Weiss G,
Knapp S.
J Clin Invest. 2013 August 1; 123(8).
2013
The scavenger receptor CD36 downmodulates the early inflammatory response while enhancing bacterial phagocytosis during pneumococcal pneumonia.
Sharif O,
Matt U,
Saluzzo S,
Lakovits K,
Haslinger I,
Furtner T,
Doninger B,
Knapp S.
J Immunol. 2013 Jun 1;190(11):5640-8. doi: 10.4049/jimmunol.1202270. Epub 2013 Apr 22.
2013
WAVE1 mediates suppression of phagocytosis by phospholipid-derived DAMPs.
Matt U,
Sharif O,
Martins R,
Furtner T,
Langeberg L,
Gawish R,
Elbau I,
Zivkovic A,
Lakovits A,
Oskolkova O,
Doninger B,
Vychytil A,
Perkmann T,
Schabbauer G,
Binder CJ,
Bochkov VN,
Scott JD,
Knapp S.
J Clin Invest. 2013 July 1; 123(7): 3014–3024. .
2012
Animal Models of Sepsis.
Knapp S.
Section Editor of this issue and Editorial. Drug Discovery Today – Disease Models Jan 2012.
2010
TLR 2 and CD14 Mediate Innate Immunity and Lung Inflammation to Staphylococcal Panton-Valentine Leukocidin In Vivo.
Zivkovic A,
Sharif O,
Stich K,
Doninger B,
Biaggio M,
Colinge J,
Bilban M,
Mesteri I,
Hazemi P,
Lemmens-Gruber R,
Knapp S.
J Immunol. 2010 Dec 22.
2007
CD14 facilitates invasive respiratory tract infections by Streptococcus pneumoniae.
Dessing M,
Knapp S,
Florquin S,
de Vos AF,
van der Poll T.
Am J Respir Crit Care Med. 2007, 175:604–611.
